[Leucine aminopeptidase (LAP)].
We regarded the aminopeptidase LAP (EC 3.4.11.1), AA (EC 3.4.11.2), and CAP (EC 3.4.11.3) as a group of enzymes and presented the method of their fractionation. In addition, we described that when an increase in serum "LAP" activity is observed, it is necessary to consider whether it is derived from LAP, AA, or CAP in order to use that data in clinical diagnosis.
Murai
T
T
D000626:Aminopeptidases / Q000097:blood; D001660:Biliary Tract Diseases / Q000175:diagnosis; D015415:Biomarkers / Q000097:blood; D005591:Chemical Fractionation / Q000379:methods; D004796:Clinical Enzyme Tests / Q000379:methods; D010122:Cystinyl Aminopeptidase / Q000097:blood; D005260:Female; D006801:Humans; D007527:Isoenzymes / Q000097:blood; D007931:Leucyl Aminopeptidase / Q000097:blood*; D008107:Liver Diseases / Q000175:diagnosis; D011247:Pregnancy; D011258:Pregnancy Tests
D015415:Biomarkers; D007527:Isoenzymes; D000626:Aminopeptidases; D007931:Leucyl Aminopeptidase; D010122:Cystinyl Aminopeptidase